Nemaura Medical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nemaura Medical Inc
Access all reports
Nemaura Medical Inc. is a medical technology company focused on the development and commercialization of non-invasive wearable devices for monitoring chronic conditions. Its flagship product is a continuous glucose monitoring system designed to help people with diabetes manage their blood sugar levels without the need for traditional fingerstick tests. Nemaura Medical leverages advanced sensor technology to provide real-time health data, supporting both patients and healthcare providers in managing diabetes and other metabolic disorders. The company is headquartered in Loughborough, England, and its shares are listed on the Nasdaq.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NMRD
Country
🇺🇸 United States